C: Use with caution if benefits outweigh challenges. Animal scientific tests show threat and human research not accessible or neither animal nor human research completed.Baseline evaluations of liver laboratory assessments are encouraged. APTIOM need to be discontinued in individuals with jaundice or other evidence of substantial liver personal inj